| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06043 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 |
| filingDate |
1978-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dc7880ba91e5632a1ef75fb3d1dd22 |
| publicationDate |
1984-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CH-641152-A5 |
| titleOfInvention |
Process for preparing thymosin alpha-1 and an analogue |
| abstract |
Process for preparing thymosin alpha 1 and its [Asn<2>] analogue by eliminating the protective groups from a compound <IMAGE> in which X represents Asn or Asp(OR<2>); R<1> represents a protective group which is customary for the hydroxyl group of serine; R<2>, R<4> and R<6> represent customary carboxyl protective groups; R<3> represents a protective group which is customary for the hydroxyl group of threonine, and R<5> represents a protective group which is customary for the omega -amino group of lysine. Thymosin alpha 1 and its [Asn<2>] analogue, as well as their pharmaceutically tolerated salts, have immunopotentiating activity and may therefore be used as drugs. |
| priorityDate |
1977-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |